We’re a leading bioscience company focused on accelerating new and innovative medical solutions for positive impact.
Stay up to date. Find out about our latest research, products, exclusive partnerships and more.
XPhyto brings together cutting-edge companies and top researchers from around the world to innovate, accelerate and commercialize disruptive technology, from drug delivery formulations to diagnostics.
Innovative and Cutting-Edge Solutions
Precision transdermal and oral drug formulations
Point-of-care (POC) diagnostics including rapid infectious disease screening
Production, formulation and validation of new active pharmaceutical ingredients (APIs)
Our research and innovation have the potential to impact lives around the world.
Learn more about how XPhyto products could change the lives of people suffering from conditions and how our new research may impact the state of our global community.
Apr 28, 2021
XPhyto delivered 2,000 of its 25-minute PCR tests to Israeli distributor for clinical evaluation and regulatory approval. Potential customers include government institutions, private healthcare providers...
Apr 21, 2021
XPhyto has entered into an agreement with an established German pharmaceutical wholesaler and service provider for the distribution, storage and logistics of XPhyto's diagnostic products...
Apr 20, 2021
XPhyto announces the appointment of Mr. Wolfgang Probst as the Chief Operations Officer (COO) of XPhyto and the addition of Mr. Manfred Buchberger as the...
Learn more about XPhyto’s innovation to impact strategy and get access to XPhyto investor information.
CSE:XPHY FSE:4XT OTCQB:XPHYF
